FDA Approves First New Hypertension Drug in 20 Years

About 23 million Americans take multiple blood pressure medications every day but still can't get their numbers under control. For the first time in 20 years, they have a new option that works differently than anything doctors have had before.

The FDA just approved Baxfendy, a first-of-its-kind medication that targets aldosterone, a hormone that drives blood pressure to dangerous levels. Instead of just managing symptoms, this drug goes after one of the root causes of stubborn hypertension.

The results from clinical trials are impressive. Patients taking the 2mg dose saw their systolic blood pressure drop by nearly 16 points. Even after accounting for the placebo effect, that's still a reduction of almost 10 points, which researchers say could reduce the risk of serious cardiovascular events by about 20%.

Dr. Bryan Williams from University College London, who led the study, said doctors have been waiting years for this kind of innovation. The drug proved effective for both people with uncontrolled hypertension and those with treatment-resistant cases, meaning it works even when other medications have failed.

High blood pressure affects 1.4 billion people worldwide and remains the leading modifiable risk factor for heart disease, stroke, kidney damage, and dementia. In the US alone, about half of people being treated for hypertension still struggle with elevated readings despite taking multiple medications.

The Ripple Effect

This approval could transform how doctors treat one of the world's most common chronic conditions. For patients who have tried everything and still see dangerous numbers on their blood pressure monitors, Baxfendy offers real hope backed by solid science.

The medication was generally well-tolerated in trials with no unexpected safety concerns. It's designed to be added to existing blood pressure medications, giving doctors a powerful new tool in their arsenal against cardiovascular disease.

John M. Clymer from the National Forum for Heart Disease & Stroke Prevention called hypertension a "staggeringly widespread silent killer." Innovative treatments like this could help tens of millions of people protect their heart, kidney, and brain health.

After two decades without major therapeutic advances, the approval marks a turning point for people living with persistently high blood pressure and the doctors working to help them stay healthy.